News Arbutus Presents New Data on AB-729, AB-836 and AB-101 at the EASL International Liver Congress™ 2022 and Provides AB-836 Clinical Update Continue Reading Previous Immunocore announces the presentation of initial data from the Phase 1 ImmTAV® trial for chronic Hepatitis B at the EASL International Liver Congress™Next Vir Biotechnology Announces New Clinical Data From its Broad Hepatitis B Program Related Stories News Benevity Releases First Enterprise Impact Platform to Solve CSR and Social Impact’s Biggest Challenges News Global Diagnostics Leader Selects Kneat News Joveo Launches First-of-Its-Kind AI Maturity Model for Talent Acquisition Teams News Aleran Software’s Digital Commerce Platform Is Certified by SAP as Built with SAP Business Technology Platform News OPTIZMO™ Releases 2024 Email Opt-Out Infographic News UK SAP Consultancy Expands to US to Address S/4HANA Migration Challenge